Levodopa response in early Parkinson’s disease
Hauser, RA, P Auinger, and D Oakes. 2009. “Levodopa Response in Early Parkinson’s Disease”. Mov Disord.
Search
Search results
1934 results found
Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation
Zesiewicz, TA, KL Sullivan, M Hoffman, LM Benes, DA Smith, CL Ward, and RA Hauser. 2008. “Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient Following Deep Brain Stimulation”. Eur Neurol.
Levetiracetam for stiff-person syndrome: report of 2 patients
Shimberg, WR, NB Patel, KL Sullivan, RA Hauser, and TA Zesiewicz. 2008. “Levetiracetam for Stiff-Person Syndrome: Report of 2 Patients”. Clin Neuropharmacol.
Optimizing bioavailability in the treatment of Parkinson’s disease.
Seeberger, LC, and RA Hauser. 2007. “Optimizing Bioavailability in the Treatment of Parkinson’s Disease.”. Neuropharmacology.
Social Security Disability Insurance (SSDI) in Parkinson’s disease.
Zesiewicz, TA, A Patel-Larson, RA Hauser, and KL Sullivan. 2007. “Social Security Disability Insurance (SSDI) in Parkinson’s Disease.”. Disabil Rehabil.
Levodopa-induced dyskinesia in Parkinson’s disease: epidemiology, etiology, and treatment.
Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “Levodopa-Induced Dyskinesia in Parkinson’s Disease: Epidemiology, Etiology, and Treatment.”. Curr Neurol Neurosci Rep .
Chorea induced by lamotrigine.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Chorea Induced by Lamotrigine.”. J Child Neurol.
Vascular hemichorea/hemiballismus and topiramate.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Vascular Hemichorea/Hemiballismus and Topiramate.”. Movement Disorders.
Long-term evaluation of deep brain stimulation of the thalamus.
Pahwa, R, KE Lyons, SB Wilkinson, RK Simpson Jr, WG Ondo, RA Hauser, and . 2006. “Long-Term Evaluation of Deep Brain Stimulation of the Thalamus.”. J Neurosurg.
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.
Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.